# OnCo record paper-ezh2-sarcoma-biochem-pharmacol-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-ezh2-sarcoma-biochem-pharmacol-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-ezh2-sarcoma-biochem-pharmacol-2023" ;
  schema:name "Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitors"@en ;
  schema:description "Review on EZH2 in Sarcomas, in Biochemical pharmacology (2023), one of the most cited Europe PMC records with EZH2 in its title."@en ;
  schema:url <https://onco.cc/key-papers/paper-ezh2-sarcoma-biochem-pharmacol-2023/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.bcp.2023.115727>, <https://pubmed.ncbi.nlm.nih.gov/37541451/>, <https://europepmc.org/article/MED/37541451> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/j.bcp.2023.115727> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Lanzi C, Arrighetti N, Pasquali S, et al." .